NDC 69448-017 – Imuldosa
Ustekinumab-srlf 45 mg/.5mL · Injection · Subcutaneous
Product NDC69448-017
Product details
- Brand name
- Imuldosa
- Generic name
- Ustekinumab-srlf
- Labeler
- Accord BioPharma Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761364
- Marketed since
- October 14, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab-srlf 45 mg/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69448-017-63 | 1 BLISTER PACK in 1 CARTON (69448-017-63) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE | Oct 14, 2024 |
Recalls mentioning this NDC
- D-0653-2026 Jul 8, 2026 · Class II
Lack of assurance of Sterility: